Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Accessed 7/2/18
However, studies using beta-3-adrenergic receptor knockout mice revealed a more complex picture: Long-term AOD-9604 treatment failed to produce weight loss in beta-3-AR knockout mice Acute administration still increased energy expenditure and fat oxidation in knockout mice This suggests beta-3-AR expression enhancement contributes to, but does not directly mediate, lipolytic effects The peptide appears to work through an unidentified receptor mechanism that subsequently influences beta-3-adrenergic signaling pathways
These typically resolve within hours and can be minimized through proper injection technique and site rotation
Peptides degrade over time, especially once reconstituted
Administration Technique: For injectable forms, proper subcutaneous injection technique, site rotation, and sterile handling minimize the risk of injection site reactions or infections
US$ 27.18
US$ 28.95
US$ 25.86
US$ 22.12